News

A new study finds that higher AGE consumption is associated with increased odds of wheezing.

Fewer patients who received masitinib 4.5 mg/kg/day reached severe dementia stage.

Peter Lio, MD, discusses the various underlying causes behind itch.

The investigators called their findings the “opposite of what was expected.”

The 5 companies issued letters will have 15 days to submit a compliance plan.

The study reports that risk is greater in female patients and those born small for gestational age. However, overall causality is still uncertain.

The study authors wrote that understanding this phenomena can lead to determining the best therapeutic strategy with DAAs for certain patients.

Cabotegravir’s FDA breakthrough designation along with adaptive strategies being deployed are the biggest stories in HIV prevention this year.

The investigators measured a 3.5-month period before and after a policy was implemented to preserve hospital resources.

FibroGen will submit additional data for the New Drug Application.

The TARGET-NASH study seeks to shed light on treatment for NASH and NAFLD.

Experts offered their advice on 2 domains, topic identification and ranking of priorities, for pediatric research realms.

In this episode of Derm Discussions, Peter Lio, MD, discusses the difficulties treating itch as well as alternative—and perhaps surprising—therapeutic options.

A discussion on how the public is still concerned with flu shot myths, and how it may influence COVID-19 vaccination and overall mitigation.

Oseltamivir and zanamivir are compared in acute treatment of patients with severe influenza type-A H1N1 in China.

Cigarette and smokeless tobacco use continues to decrease rapidly among teenagers, but e-cigarette use is on the rise.

A discussion with a survey researcher on the 35% of US adults who state they won't get the vaccine this season.

The authorization to Moderna is the second in as many weeks for a COVID-19 vaccine, following Pfizer's.

Novartis indicates they will address manufacturing issues cited by the FDA.

Patients with any presence of small vessel disease had a 2-times greater risk of recurrent ischemic stroke than those without.

Hepatitis B coinfection with COVID-19 did not increase either disease’s severity or increase duration of hospitalization, according to a small study in China.

Using French data, there were 3 times as many deaths from COVID-19 than the Flu in France, despite a shorter study time.

There were similar rates of primary outcome events in the high-dose and standard-dose vaccination groups.

Harvey Alter, Michael Houghton, and Charles Rice were awarded with the 2020 Nobel Prize in Physiology and Medicine.

FLT3-mutated patients achieved favorable antileukemic responses regardless of anthracycline type or gilteritinib dosing regimen.

Despite these findings, there is still uncertainty as to whether mitigating symptoms of depression can lower cardiovascular risk.

The agency is expected to rule on the Novartis treatment in 2021.

The FDA approvals of biologics for atopic dermatitis and psoriasis have ushered in a new era for the once-stagnant field of pediatric dermatology.